MANAGING DIRECTOR, GENERAL MANAGER & BUSINESS STRATEGY CONSULTANT, HASBIOTECH
Founded in 2009, Hasbiotech is driven to create and manufacture an original Turkish medicine starting from scratch and is establishing a manufacturing site for local production of biotechnological products.
Tüm Ekip Pharmaceuticals was established in 2000 and is a specialized injectable pharmaceutical producer, with capability to produce seven different sterile forms.
Established in the year 2002, Surya Life Sciences is a manufacturer, exporter, and supplier of a wide assortment of bulk drug intermediates and fine API chemicals.
Centurion Pharma was founded in 1979, and today imports products for the treatment of rare diseases as well as biological, biotechnological and hospital products. Centurion has also taken steps to develop and manufacture products locally by establishing an R&D Department in 2011.
Sanofi has a diversified portfolio, ranging from innovative medicines including rare diseases, immunology, diabetes and cardiovascular to consumer healthcare products and vaccines.
CHIEF SENIOR RESEARCHER, TUBITAK MAM, GENETIC ENGINEERING AND BIOTECHNOLOGY INSTITUTE (GEBI)
The Genetic Engineering and Biotechnology Institute (GEBI) conducts researches and develops technologies in the field of genetic engineering and biotechnology with high added value by taking into consideration the developments in the world and the needs of the public and industrial sectors in Turkey.
TR-PHARM, founded in 2013, is a marketer of pharmaceuticals and biopharmaceuticals with a focus on high-tech R&D and the ambition to gain global recognition in bringing high-quality and cost-effective solutions in the healthcare industry.
Active since 1958, DEVA is a generics company with approximately 600 products ranging from APIs, formulations, sterile injectables and ampoules, BFS eye drops and animal health products.
In August 2023, Mexican exports to the US surpassed China for the first time. As companies prioritize securing supply their chains after years of logistics challenges, Mexico has begun to see major benefits. With a spate of new infrastructure projects such as the Interoceanic Corridor of the Isthmus of Tehuantepec coming online in 2023, the country is actively opening itself to investment. The chemical industry, in particular, is positioned for nearshoring-driven growth.